In pharmacological treatment, growth hormone can counteract the accumulation of ROS by activating the PI3K/AKT signaling pathway and the apoptosis of GCs of patients with PCOS by downregulating CASP-3 and caspase-9 (CASP-9). Here, CASP9 is linked to polycystic ovary syndrome.